As a journalist, I rearranged the order of paragraphs and moved text around to create a new article. Here it is:
CVS Health® is at the forefront of promoting the use of high-quality, cost-effective medications, including biosimilar drugs. These drugs are essential for patients with chronic and severe conditions, as they offer an affordable alternative for treatment. From cancer to diabetes, biosimilars have the potential to significantly reduce drug costs in today’s healthcare system.
In a recent report written by Dr. Sree Chaguturu, EVP and CMO of CVS Health, the benefits of biosimilar drugs in making treatments more accessible were highlighted. The report also showcased Cordavis™, a CVS Health subsidiary that specializes in producing top-notch biosimilars. Through their efforts, Cordavis™ is improving patient access to these life-changing medications and driving innovation in the field of healthcare.
For more information about the impact of biosimilar drugs and how they are revolutionizing the healthcare industry, you can access the full report (PDF) on CVS Health’s website.
